Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Marcus

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
AJR. American Journal of Roentgenology|May 23, 2015
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral CavityMohammed A Pasha, Charles Marcus, Carole Fakhry, et al.
AJR. American Journal of Roentgenology|October 28, 2020
Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CTCharles Marcus, Parissa Feizi, Jeffery Hogg, et al.
Medicine|August 11, 2018
Adding value to myocardial perfusion SPECT/CT studies that include coronary calcium CT: Detection of incidental pulmonary arterial dilatationCharles Marcus, Prasanna Santhanam, Matthew J Kruse, et al.
Clinical Nuclear Medicine|March 3, 2025
Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell AnemiaIsmaheel O Lawal, Olumide B Gbolahan, Charles Marcus, et al.
AJR. American Journal of Roentgenology|July 23, 2016
JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient SurvivalCharles Marcus, Rick Wray, Mehdi Taghipour, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up <sup>18</sup>F-FDG PET/CT Scans in Oncology PatientsMehdi Taghipour, Charles Marcus, Sara Sheikhbahaei, et al.
Physics in Medicine and Biology|December 8, 2015
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome predictionArman Rahmim, C Ross Schmidtlein, Andrew Jackson, et al.
Research Square|May 19, 2025
Bladder activity of different PSMA PET radioligands and impact of furosemideIsmaheel Lawal, Aliza Mushtaq, Samuel Gitau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2014
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomesCharles Marcus, Anthony Ciarallo, Abdel K Tahari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2022
Diagnostic performance of IQ·SPECT with high-speed scanning: A preliminary quality control study in obese patientsRudolf A Werner, Ricardo Bello Martinez, Charles Marcus, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
AJR. American Journal of Roentgenology|May 23, 2015
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral CavityMohammed A Pasha, Charles Marcus, Carole Fakhry, et al.
AJR. American Journal of Roentgenology|October 28, 2020
Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CTCharles Marcus, Parissa Feizi, Jeffery Hogg, et al.
Medicine|August 11, 2018
Adding value to myocardial perfusion SPECT/CT studies that include coronary calcium CT: Detection of incidental pulmonary arterial dilatationCharles Marcus, Prasanna Santhanam, Matthew J Kruse, et al.
Clinical Nuclear Medicine|March 3, 2025
Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell AnemiaIsmaheel O Lawal, Olumide B Gbolahan, Charles Marcus, et al.
AJR. American Journal of Roentgenology|July 23, 2016
JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient SurvivalCharles Marcus, Rick Wray, Mehdi Taghipour, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up <sup>18</sup>F-FDG PET/CT Scans in Oncology PatientsMehdi Taghipour, Charles Marcus, Sara Sheikhbahaei, et al.
Physics in Medicine and Biology|December 8, 2015
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome predictionArman Rahmim, C Ross Schmidtlein, Andrew Jackson, et al.
Research Square|May 19, 2025
Bladder activity of different PSMA PET radioligands and impact of furosemideIsmaheel Lawal, Aliza Mushtaq, Samuel Gitau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2014
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomesCharles Marcus, Anthony Ciarallo, Abdel K Tahari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 7, 2022
Diagnostic performance of IQ·SPECT with high-speed scanning: A preliminary quality control study in obese patientsRudolf A Werner, Ricardo Bello Martinez, Charles Marcus, et al.
Pageof 6